LCM
ALT icon

Lynwood Capital Management’s Altimmune ALT Stock Holding History

Lynwood Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.53M Buy
+150,000
New +$1.53M 9.05% 4

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Lynwood Capital Management's ALT Position: Q1 2024 in Review

Lynwood Capital Management opened a new position in Altimmune (ALT) in Q1 2024: 150,000 shares worth $1.53M. The stake represents 9.05% of the portfolio and ranks #4 among its holdings.

172 funds tracked by Wall St. Rank hold ALT as of Q1 2024.

  • Lynwood Capital Management held 150,000 shares of Altimmune worth $1.53M as of Q1 2024.
  • Altimmune was a new Lynwood Capital Management position in Q1 2024.
  • Altimmune made up 9.05% of Lynwood Capital Management's portfolio in Q1 2024, its #4 holding.
  • 172 funds tracked by Wall St. Rank held Altimmune as of Q1 2024.

Based on Lynwood Capital Management's 13F filing for Q1 2024, filed 10 May 2024.